NCT01403818

A Study to Assess the Effect of ASP1941 and Mitiglinide on Their Plasma Concentration

Pharmacokinetic Study of ASP1941 -A Pharmacokinetic Study to Assess Drug-Drug Interaction Between ASP1941 and Mitiglinide Calcium Hydrate

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Astellas Pharma Inc · Industry
• Sex: Male
• Age: 20 Years – 44 Years
• Healthy volunteers: Accepted

Summary

This study is to assess the pharmacokinetic interaction between ASP1941 and Mitiglinide calcium hydrate in healthy volunteers.

Detailed description

This will be a randomized, open label, four group, two-way crossover design study to assess the effect of drug interaction between ASP1941 and Mitiglinide calcium hydrate on the pharmacokinetics of them after separate and concomitant administration to healthy non-elderly adult male subjects.

Conditions

• Healthy
• Pharmacokinetics of ASP1941
• Pharmacokinetics of Mitiglinide

Interventions

Type	Name	Description
DRUG	ASP1941	oral
DRUG	Mitiglinide calcium hydrate	oral

Timeline

• Start date: 2011-06-01
• Primary completion: 2011-08-01
• Completion: 2011-08-01
• First posted: 2011-07-27
• Last updated: 2011-10-12

Locations

1 site across 1 country: Japan